
HOMA IR C - Peptide Model










The HOMA IR C - Peptide Model is a group of blood tests that check how well the body responds to insulin (insulin sensitivity) and the function of insulin-producing cells (beta cells) using the fasting blood sugar and C-peptide levels to provide important information about the overall metabolic health. This is a more advanced panel to detect insulin resistance as it measures C-peptide levels and is useful in diabetic patients receiving exogenous insulin.













Understanding HOMA IR C - Peptide Model
The HOMA IR C - Peptide Model test is a simple, non-invasive way to check how well the body responds to insulin, how it uses sugar (glucose metabolism), and how well the pancreas works. This test helps detect insulin resistance, a key problem that develops when the body’s cells don’t respond well to insulin, resulting in high blood sugar levels leading to diabetes and heart diseases.
The HOMA IR C - Peptide Model uses HOMA 2; a mathematical index that determines insulin sensitivity and function of the beta cells. It is calculated from fasting blood sugar and C-peptide levels. Homeostatic model assessment (HOMA-2) is a method for assessing function of beta-cells of pancreas and estimating insulin resistance (IR) from basal (fasting) glucose and C-peptide concentrations.The C-Peptide model used C-peptide fasting (a protein released from pancreas when it secretes insulin) in place of Insulin fasting and is considered a better indicator than serum insulin itself.
The insights from HOMA IR C - Peptide Model test help doctors determine how well the body uses sugar and diagnose conditions such as insulin resistance, problems with blood sugar control, etc., and diseases like diabetes.
Usually, overnight fasting (8 to 12 hours) is required before the HOMA IR C - Peptide Model test. Do not eat or drink anything except water before the test. Inform the doctor about any medications, supplements, or herbal remedies being taken, as some may interfere with the test results and require dosage adjustments or temporary discontinuation.
Test result ranges are approximate and may differ slightly between labs depending on the methodology and laboratory guidelines. Talk to the doctor about the specific test results. The results will help doctors identify individuals at risk of metabolic dysfunction, enabling early intervention strategies such as lifestyle modifications, medications, etc. Also, the results will help doctors make informed decisions regarding medication adjustments and implement diet and lifestyle changes to optimize diabetes management and improve overall health.
What does HOMA IR C - Peptide Model measure?
Contains 5 testsThe HOMA IR C - Peptide Model test helps evaluate insulin resistance and how well the pancreas works by measuring fasting blood sugar and C-peptide levels. Unlike traditional insulin-based models, the C-peptide version of HOMA is better suited for individuals taking insulin injections, as C-peptide is not affected by injected insulin. This test gives a clearer picture of how much insulin the body is naturally making, which helps doctors understand how well the pancreas is functioning.
The test uses a formula with fasting glucose and C-peptide levels to measure insulin sensitivity. This is important for identifying individuals who are at risk of type 2 diabetes and other health problems. The HOMA IR C - Peptide Model test is also useful for tracking insulin sensitivity over time, allowing doctors to see how well treatments are working and adjust them if needed. It helps doctors and patients understand how insulin works in the body, which can help reduce the risk of diabetes and heart disease.
The FBS (Fasting Blood Sugar) test measures the glucose level in the body under overnight fasting conditions. Glucose is the primary energy source and is broken down through metabolism to produce energy. Hormones and enzymes produced by the liver and pancreas control this process. The hormone insulin, produced by the pancreas, regulates blood glucose levels. When these levels are high, such as after a meal, insulin is secreted to transport glucose into cells for energy production. Elevated fasting glucose levels may indicate a risk of developing prediabetes or diabetes. Diabetes is broadly classified into two main types. Type 1 diabetes occurs when the pancreas produces little or no insulin due to autoimmune destruction of insulin-producing cells. Type 2 diabetes develops when the body becomes resistant to insulin or when insulin production is insufficient to meet the body’s needs.
Know more about FBS (Fasting Blood Sugar)
The C-Peptide, Fasting test measures the level of C-peptide in the blood. C-peptide is a byproduct of insulin production in the pancreas. When the pancreas releases insulin into the blood, it also releases C-peptide in equal amounts. Therefore, measuring C-peptide levels can provide valuable insights into the body's natural production of insulin. This test is particularly useful in individuals with diabetes, as it helps determine how well their pancreas is functioning in producing insulin.
By assessing C-peptide levels, doctors can better understand an individual's insulin production capacity. This information is crucial for diagnosing and managing diabetes effectively. Additionally, the C-Peptide, Fasting test can help differentiate between type 1 and type 2 diabetes, guide treatment decisions, monitor the effectiveness of diabetes therapies, and evaluate overall pancreatic function Moreover, the C-Peptide, Fasting test plays a vital role in tailoring personalized treatment plans for individuals with diabetes, ensuring optimal management of their condition.
Know more about C-Peptide, Fasting





FAQs related to HOMA IR C - Peptide Model
- Khan HA, Sobki SH, Ekhzaimy A, Khan I, Almusawi MA. Biomarker potential of C-peptide for screening of insulin resistance in diabetic and non-diabetic individuals. Saudi J Biol Sci. 2018 Dec;25(8):1729-1732. [Accessed 25 Oct. 2024]. Available from:
- Taylor R. Insulin resistance and type 2 diabetes. Diabetes. 2012 Apr;61(4):778-9. [Accessed 25 Oct. 2024]. Available from:
- Qu HQ, Li Q, Rentfro AR, Fisher-Hoch SP, McCormick JB. The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning. PLoS One. 2011;6(6):e21041. [Accessed 25 Oct. 2024]. Available from:
- de Cassia da Silva C, Zambon MP, Vasques ACJ, Camilo DF, de Góes Monteiro Antonio MÂR, Geloneze B. The threshold value for identifying insulin resistance (HOMA-IR) in an admixed adolescent population: A hyperglycemic clamp validated study. Arch Endocrinol Metab. 2023 Jan 18;67(1):119-125. [Accessed 25 Oct. 2024]. Available from:
- Freeman AM, Acevedo LA, Pennings N. Insulin Resistance. [Updated 2023 Aug 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from:
Other tests
- PPBS (Postprandial Blood Sugar)
- FBS (Fasting Blood Sugar)
- HbA1c (Glycosylated Hemoglobin)
- Diabetes Screening (HbA1C & Fasting Sugar)
- RBS (Random Blood Sugar)
- Insulin, Fasting
- Microalbumin Creatinine Ratio, Urine
- Glucose Challenge Test, Pregnancy DIPSI, 75g Glucose, 2hrs
- HOMA IR; Insulin Resistance Index
- Lipase
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)





















